In March 2020 at the start of the Covid-19 Pandemic, Harvard University took immediate preventative measures to protect its students and employees. By May 2020, the University announced its research laboratory re-entry plan including prevention of workplace exposure and limiting contact within our research laboratories. The department in collaboration with the FAS continues to maintain many of these measures. Information and resources about Covid-19 workplace safety can be found at the link below.
Combating disease and tissue degeneration and improving human health.
This is the ultimate goal of HSCRB’s research, whether it is focused on the most basic level of cellular development or screening chemical compounds for potential drugs. Our mission is to push the frontiers of stem cell and regenerative biology, illuminating the workings of human health and disease in both basic discovery and clinical settings.
The best place to learn about stem cell science, at the graduate and undergraduate level.
HSCRB is the place to learn about stem cell science at both the graduate level and the undergraduate level. We are committed to transforming medicine by cultivating a deeper knowledge of stem cell and regenerative biology, and to training the next generation to explore new frontiers in biomedical science. All of our students conduct independent research.
HSCRB by the numbers
Papers published in Cell, Nature, Science, and their high-impact sister journals
Undergraduates who conduct independent research
Collaborating local institutes and hospitals
Startup companies founded by our faculty
New Vranos Family Foundation Grant Focuses on Reducing the Impact of Brain Aging
A new concerted effort, supported by the Vranos Family Foundation, aims to align expertise from across FAS and HMS to challenge the concept that functional decline associated with aging is irreversible.
Kara McKinley named Packard Fellow for Science and Engineering
Dr. McKinley and 19 other innovative early-career scientists and engineers will each receive $875,000 over five years to pursue their research.
Kara McKinley Receives NIH Director’s New Innovator Award
Dr. McKinley will receive $1.5 million over five years to continue her work in uterine regeneration, focused on establishing an animal model of menstruation.